Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Comparing two surgical methods for pancreatic cancer treatment

Official title: Total Laparoscopic Pancreaticoduodenectomy Versus Open Pancreaticoduodenectomy for Pancreatic Carcinoma(TJDBPS07) a Multicenter Randomized Controlled Trial

Run by Tongji Hospital · NCT03785743 · Data updated 2026-11-12

This study is testing if a less invasive surgery for pancreatic cancer works better than traditional surgery in helping patients live longer after treatment.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment200 (estimated)
SponsorTongji Hospital
Academic / other
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedMarch 1, 2019
Main results expectedMarch 1, 2027
Study endsMay 1, 2027
Registry record updatedMarch 2, 2022
Trial IDNCT03785743 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 75 with histologically confirmed or clinically diagnosed pancreatic ductal adenocarcinoma who are eligible for both surgical techniques.

Probably not a fit

Patients with distant metastases, severe comorbidities, or those requiring palliative surgery will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of total laparoscopic pancreaticoduodenectomy (TLPD) versus open pancreaticoduodenectomy (OPD) in patients with pancreatic carcinoma. It is a multicenter, prospective, randomized controlled trial involving 200 patients who will be allocated to either surgical group. The study focuses on evaluating overall survival rates while implementing an enhanced recovery after surgery (ERAS) protocol. The trial addresses the ongoing debate regarding the superiority of minimally invasive surgery compared to traditional open surgery for this aggressive cancer.

Why it matters

Potential benefit: If successful, this study could provide insights into which surgical approach offers better survival outcomes for patients with pancreatic cancer.

How similar studies have gone: While studies comparing laparoscopic and open surgery exist, this trial is significant as it is a randomized controlled trial specifically designed to address the lack of robust evidence in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 years and 75 years.
2. Histologically confirmed PDAC or clinically diagnosed PDAC by an MDT without histopathologic evidence.
3. Patients feasible to undergo both LPD and OPD according to MDT evaluations.
4. Patients understanding and willing to comply with this trial.
5. Provision of written informed consent before patient registration.
6. Patients meeting the curative treatment intent in accordance with clinical guidelines.

Exclusion Criteria:

1. Patients with distant metastases, including peritoneal, liver, distant lymph node metastases, and involvement of other organs.
2. Patients requiring left, central or total pancreatectomy or other palliative surgery.
3. Preoperative American Society of Anaesthesiologists (ASA) score ≥ 4.
4. History of other malignant disease.
5. Pregnant or breast-feeding women.
6. Patients with serious mental disorders.
7. Patients treated with neoadjuvant therapy.
8. Patients with vascular invasion and requiring vascular resection as evaluated by the MDT team according to abdominal imaging data.
9. Body mass index \> 35 kg/m2.
10. Patients participating in any other clinical trials within 3 months.

Where it's running

  • Department of Biliary and Pancreatic Surgery, Tongji Hospital, Affiliated Tongji Medical College, Huazhong University of Science and Technology
    Wuhan, Hubei, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.